Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization

Journal of Infectious Diseases

Volumn 210, Issue 12, 2014, Pages 1981-1990

  Nahrendorf, Wiebke ^a,c   Scholzen, Anja ^a   Bijker, Else M ^a   Teirlinck, Anne C ^a,d   Bastiaens, Guido J H ^a   Schats, Remko ^b   Hermsen, Cornelus C ^a   Visser, Leo G ^b   Langhorne, Jean ^c   Sauerwein, Robert W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Antibody; Immunization; Malaria; Memory B cell; Plasmodium; Protection; Sporozoite

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; CIRCUMSPOROZOITE PROTEIN; LIVER STAGE ANTIGEN 1; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; PARASITE ANTIGEN; UNCLASSIFIED DRUG; PROTOZOON ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; MALARIA FALCIPARUM; MEMORY CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPOROZOITE; ADULT; B LYMPHOCYTE; BLOOD; CONTROLLED STUDY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; PLASMODIUM FALCIPARUM; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIBODIES, PROTOZOAN; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; HEALTHY VOLUNTEERS; HUMANS; IMMUNIZATION; IMMUNOLOGIC MEMORY; MALARIA VACCINES; PLASMODIUM FALCIPARUM; SPOROZOITES;

EID: 84920085920     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu354     Document Type: Article

References (45)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128.
2. Sauerwein RW. Clinical malaria vaccine development. Immunol Lett 2009;122:115-7.
3. Druilhe P, Barnwell JW. Pre-erythrocytic stage malaria vaccines: time for a change in path. Curr Opin Microbiol 2007;10:371-8.
4. Riley EM, Stewart VA. Immune mechanisms in malaria: new insights in vaccine development. Nat Med 2013;19:168-78.
5. Kester KE, Cummings JF, Ofori-Anyinam O, et al. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS, S/AS01B and RTS, S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J Infect Dis 2009;200:337-46.
6. Bejon P, White MT, Olotu A, et al. Efficacy of RTS, S malaria vaccines: individual-participant pooled analysis of phase 2 data. Lancet Infect Dis 2013;13:319-27.
7. Olotu A, Fegan G, Wambua J, et al. Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure. N Engl J Med 2013;368:1111-20.
8. Butler NS, Vaughan AM, Harty JT, Kappe SH. Whole parasite vaccination approaches for prevention of malaria infection. Trends Immunol 2012;33:247-54.
9. Clyde DF, Most H, McCarthy VC, Vanderberg JP. Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci 1973;266:169-77.
10. Seder RA, Chang LJ, Enama ME, et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 2013;341:1359-65.
11. Roestenberg M, McCall M, Hopman J, et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 2009;361:468-77.
12. Roestenberg M, Teirlinck AC, McCall MB, et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 2011;377:1770-6.
13. Bijker EM, Bastiaens GJ, Teirlinck AC, et al. Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc Natl Acad Sci U S A 2013;110:7862-7.
14. Belnoue E, Costa FT, Frankenberg T, et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 2004;172:2487-95.
15. Plotkin SA. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 2008;47:401-9.
16. Tangye SG. Staying alive: regulation of plasma cell survival. Trends Immunol 2011;32:595-602.
17. Tangye SG, Tarlinton DM. Memory B cells: effectors of long-lived immune responses. Eur J Immunol 2009;39:2065-75.
18. McHeyzer-Williams M, Okitsu S, Wang N, McHeyzer-Williams L. Molecular programming of B cell memory. Nat Rev Immunol 2012;12:24-34.
19. Cohen S, Mc GI, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961;192:733-7.
20. Bijker EM, Teirlinck AC, Schats R, et al. Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites. J Infect Dis 2014;210:1605-15.
21. Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigenspecific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004;286:111-22.
22. Weiss GE, Ndungu FM, McKittrick N, et al. High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infections. J Immunol Methods, 2012;375:68-74.
23. Felgner PL, Roestenberg M, Liang L, et al. Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Sci Rep 2013;3:3549.
24. Vaughan AM, Mikolajczak SA, Wilson EM, et al. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest 2012;122:3618-28.
25. Hollingdale MR, Leland P, Leef JL, Leef MF, Beaudoin RL. Serological reactivity of in vitro cultured exoerythrocytic stages of Plasmodium berghei in indirect immunofluorescent or immunoperoxidase antibody tests. Am J Trop Med Hyg 1983;32:24-30.
26. Singh AP, Buscaglia CA, Wang Q, et al. Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell 2007;131:492-504.
27. Ndungu FM, Olotu A, Mwacharo J, et al. Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children. Proc Natl Acad Sci U S A 2012;109:8247-52.
28. Ampomah P, Stevenson L, Ofori MF, Barfod L, Hviid L. Kinetics of B cell responses to Plasmodium falciparum erythrocyte membrane protein 1 in ghanaian women naturally exposed to malaria parasites. J Immunol 2014;192:5236-44.
29. Weiss GE, Traore B, Kayentao K, et al. The Plasmodium falciparumspecific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog 2010;6:e1000912.
30. Dicko A, Diemert DJ, Sagara I, et al. Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians. PLoS One 2007;2:e1045.
31. Liu XQ, Stacey KJ, Horne-Debets JM, et al. Malaria infection alters the expression of B-cell activating factor resulting in diminished memory antibody responses and survival. Eur J Immunol 2012;42:3291-301.
32. Wykes MN, Zhou YH, Liu XQ, Good MF. Plasmodium yoelii can ablate vaccine-induced long-term protection in mice. J Immunol 2005;175:2510-6.
33. Ewer KJ, O'Hara GA, Duncan CJ, et al. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nat Commun 2013;4:2836.
34. Sharma P, Bharadwaj A, Bhasin VK, Sailaja VN, Chauhan VS. Antibodies to a conserved-motif peptide sequence of the Plasmodium falciparum thrombospondin-related anonymous protein and circumsporozoite protein recognize a 78-kilodalton protein in the asexual blood stages of the parasite and inhibit merozoite invasion in vitro. Infect Immun 1996;64:2172-9.
35. Cowan G, Krishna S, Crisanti A, Robson K. Expression of thrombospondin-related anonymous protein in Plasmodium falciparum sporozoites. Lancet 1992;339:1412-3.
36. Webster HK, Gingrich JB, Wongsrichanalai C, et al. Circumsporozoite antibody as a serologic marker of Plasmodium falciparum transmission. Am J Trop Med Hyg 1992;47:489-97.
37. Potocnjak P, Yoshida N, Nussenzweig RS, Nussenzweig V. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J Exp Med 1980;151:1504-13.
38. Gysin J, Barnwell J, Schlesinger DH, Nussenzweig V, Nussenzweig RS. Neutralization of the infectivity of sporozoites of Plasmodium knowlesi by antibodies to a synthetic peptide. J Exp Med 1984;160:935-40.
39. Foquet L, Hermsen CC, van Gemert GJ, et al. Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. J Clin Invest 2014;124:140-4.
40. Gruner AC, Mauduit M, Tewari R, et al. Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS One 2007;2:e1371.
41. Kumar KA, Sano G, Boscardin S, et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 2006;444:937-40.
42. Trieu A, Kayala MA, Burk C, et al. Sterile protective immunity to malaria is associated with a panel of novel P.falciparum antigens. Mole Cell Proteomics 2011;10:M111 007948.
43. Doolan DL, Mu Y, Unal B, et al. Profiling humoral immune responses to P.falciparum infection with protein microarrays. Proteomics 2008;8:4680-94.
44. John CC, Moormann AM, Pregibon DC, et al. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. Am J Trop Med Hyg 2005;73:222-8.
45. Behet MC, Foquet L, van Gemert GJ, et al. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Malar J 2014;13:136.